Borderline personality disorder (BPD) appears to comprise symptoms that are
manifestations of acute illness as well as symptoms that represent more
enduring aspects of the disorder.
The former are akin to the positive symptoms of schizophrenia and the
latter are akin to the negative symptoms of schizophrenia, according to a
longitudinal study of BPD patients in the June American Journal of
Psychiatry.
Researchers assessed the borderline psychopathology of 362 patients with
personality disorders using two semistructured interviews of proven
reliability.
All patients were recruited during inpatient stays.
Of these, 290 patients met DSM-III-R criteria as well as Revised
Diagnostic Interview for Borderlines criteria for BPD, and 72 met
DSM-III-R criteria for another Axis II disorder. Over 85 percent of
the patients were interviewed again at five distinct two-year follow-up waves
by interviewers blind to all previously collected information.
Twenty-four symptoms were studied at baseline and follow-up (see
FIG1).
Twelve of the 24 symptoms studied showed patterns of sharp decline over
time and were reported at 10-year follow-up by less than 15 percent of the
patients who reported them at baseline. The other 12 symptoms showed patterns
of substantial but less dramatic decline over the follow-up period.
Symptoms reflecting core areas of impulsivity (such as self-mutilation and
suicide efforts), and active attempts to manage interpersonal difficulties
(such as problems with demandingness/entitlement and serious treatment
regressions) seemed to resolve the most quickly.
In contrast, affective symptoms reflecting areas of chronic dysphoria (such
as anger, loneliness, or emptiness) and interpersonal symptoms reflecting
abandonment and dependency issues (such as intolerance of aloneness and
problems with dependency) seemed to be the most enduring.
Lead author Mary Zanarini, Ed.D., told Psychiatric News that many
of the patients received treatment over time, but as the study was
naturalistic, they were not randomized to standardized treatments. "One
cannot say much about the relationship between treatment and symptomatic
outcome," she said. "Treatment may have helped, hurt, done little,
or some combination of the three at different times."
She said the findings have important clinical implications.
"Temperamental symptoms interfere with psychosocial functioning, yet
no treatment has been developed to treat them," she said. "In
fact, many psychotherapies end before these symptoms can be addressed. We need
to develop therapies to address these troublesome symptoms. This would change
the treatment that many borderline patients receive, making their
temperamental symptoms as much the focus of therapy as their acute
symptoms."
She is an associate professor of psychology at Harvard Medical School and
director of the laboratory for the study of adult development at McLean
Hospital in Belmont, Mass.
Joel Paris, M.D., said the study confirmed his own research and that of
others showing that patients with BPD are liable to continue to have symptoms
of mental illness well after the core symptoms of BPD have resolved.
He cited the Collaborative Longitudinal Personal Disorders Study (CLPS),
which was summarized in the October 2005 Journal of Personality
Disorders.
"In the CLPS study, we found that people got better over time,"
Paris said. "They didn't meet criteria for BPD because they stopped
doing the really impulsive things. But they continued to be really
unhappy."
He is a professor and chair of the Department of Psychiatry at McGill
University in Montreal and editor in chief of the Canadian Journal of
Psychiatry. He is also a past president of the Association for Research
in Personality Disorders.
The study was supported by grants from the National Institute of Mental
Health.
"The Subsyndromal Phenomenology of Borderline Personality
Disorder: A 10-Year Follow-Up Study" is posted at<http://ajp.psychiatryonline.org/>
under the June issue. ▪